Vanguard Fiduciary Trust
AGIO icon

Vanguard Fiduciary Trust’s Agios Pharmaceuticals AGIO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Buy
395,868
+13,847
+4% +$420K ﹤0.01% 1605
2026
Q1 		$12.9M Buy
+382,021
New +$10.8M ﹤0.01% 1570

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Vanguard Fiduciary Trust's AGIO Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Agios Pharmaceuticals (AGIO) stake by 3.6% in Q2 2026, buying an estimated $420K and bringing the position to 395,868 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

Vanguard Fiduciary Trust first reported a position in AGIO in Q1 2026 and has held it in 2 quarters since. 236 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Vanguard Fiduciary Trust held 395,868 shares of Agios Pharmaceuticals worth $14.7M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 13,847 Agios Pharmaceuticals shares in Q2 2026, an estimated $420K.
  • Agios Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1605 holding.
  • Vanguard Fiduciary Trust first reported a position in Agios Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 236 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.